AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32948577 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 200000
Study 34295867 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective gear
Number of subjects: 65
Study 34295867 — intervention group
Group type: COMPARATOR
Intervention: Civilian clothes (Control)
Number of subjects: 65
Study 34295867 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 65
Study 33139709 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic faces (happy, angry)
Number of subjects: 222
Study 33139709 — intervention group
Group type: COMPARATOR
Intervention: Dynamic flowers
Number of subjects: 222
Study 33139709 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing happy compared to angry faces
Number of subjects: 222
Study 34146521 — intervention group
Group type: EXPERIMENTAL
Intervention: HF-DMP
Number of subjects: 671
Study 34146521 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 671
Study 33882913 — intervention group
Group type: EXPERIMENTAL
Intervention: mini-CEX assessments
Number of subjects: 38
Study 33882913 — intervention group
Group type: COMPARATOR
Intervention: ad-hoc feedback
Number of subjects: 38
Study 33575846 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 442
Study 33575846 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant Radiotherapy (RT)
Number of subjects: 442
Study 33575846 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant treatment (RT or RCT)
Number of subjects: 442
Study 33575846 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant radio(chemo)therapy (RCT and RT)
Number of subjects: 442
Study 33575846 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant therapy
Number of subjects: 442
Study 32956682 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 12
Study 32956682 — intervention group
Group type: COMPARATOR
Intervention: Cathodal tDCS
Number of subjects: 12
Study 32956682 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study 36229112 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Intervention (n=19)
Number of subjects: 44
Study 36229112 — intervention group
Group type: COMPARATOR
Intervention: Supportive Psychotherapy (n=25)
Number of subjects: 44
Study 32691125 — intervention group
Group type: EXPERIMENTAL
Intervention: AiMAR 4
Number of subjects: 25
Study 32691125 — intervention group
Group type: EXPERIMENTAL
Intervention: AiMAR 5
Number of subjects: 25
Study 32691125 — intervention group
Group type: COMPARATOR
Intervention: Original images
Number of subjects: 25
Study 32412145 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructional self-talk
Number of subjects: 40
Study 32412145 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational self-talk
Number of subjects: 40
Study 35971073 — intervention group
Group type: EXPERIMENTAL
Intervention: Care manager-led information provision and practical support
Number of subjects: 53
Study 35971073 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 53
Study 33978187 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg elemental iron as ferrous sulfate for 12 weeks
Number of subjects: 407
Study 33978187 — intervention group
Group type: EXPERIMENTAL
Intervention: Hb as measured with a hematology analyzer
Number of subjects: 407
Study 33978187 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflammation-adjusted ferritin
Number of subjects: 407
Study 33978187 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepcidin
Number of subjects: 407
Study 33978187 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflammation-adjusted total body iron stores (TBIS)
Number of subjects: 407
Study 33978187 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined predictive ability of Hb (hematology analyzer), inflammation-adjusted ferritin, and hepcidin
Number of subjects: 407
Study 33978187 — intervention group
Group type: EXPERIMENTAL
Intervention: Hb measured with the HemoCue
Number of subjects: 407
Study 32942935 — intervention group
Group type: EXPERIMENTAL
Intervention: PD‐LTF+ group (19 patients)
Number of subjects: 38
Study 32942935 — intervention group
Group type: COMPARATOR
Intervention: PD‐LTF- group (19 patients)
Number of subjects: 38
Study 33663545 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaine supplementation (2 g/day)
Number of subjects: 29
Study 33663545 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (PG)
Number of subjects: 29
Study 35094931 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive tendon-loading exercise therapy
Number of subjects: 76
Study 35094931 — intervention group
Group type: COMPARATOR
Intervention: Eccentric exercise therapy
Number of subjects: 76
Study 33605796 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple bolus computerized tomography
Number of subjects: 200
Study 33605796 — intervention group
Group type: COMPARATOR
Intervention: Conventional computerized tomography
Number of subjects: 200
Study 33368114 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg daily for 45 days
Number of subjects: 85
Study 33368114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 33368114 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 85
Study 36259883 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary reverse mapping and selective axillary dissection (ARM-SAD)
Number of subjects: 130
Study 36259883 — intervention group
Group type: COMPARATOR
Intervention: Standard axillary dissection (AD)
Number of subjects: 130
Study 33043344 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral ultrasonic imaging
Number of subjects: 18
Study 35318115 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (administered at birth, 1 month, and 6 months)
Number of subjects: 82366
Study 35318115 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 82366
Study 35318115 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine
Number of subjects: 82366
Study 32762513 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 177
Study 32762513 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 177
Study 34544780 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical examination and a two-point PoCUS scan
Number of subjects: 1206
Study 34544780 — intervention group
Group type: COMPARATOR
Intervention: Physical examination only
Number of subjects: 1206
Study 36328489 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional imaging plus 18F-fluciclovine PET/CT (arm B)
Number of subjects: 157
Study 36328489 — intervention group
Group type: COMPARATOR
Intervention: Conventional imaging only (arm A)
Number of subjects: 157
Study 33330915 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucine intake ranging from 20 to 120 mg . kg‐1 . d‐1
Number of subjects: 16
Study 33330915 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucine intake based on fat-free mass
Number of subjects: 16
Study 35709830 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g of donor feces
Number of subjects: 125
Study 35709830 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 g of donor feces
Number of subjects: 125
Study 35709830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 33676533 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariate-constrained randomization (CCR) methods
Number of subjects: 0
Study 33676533 — intervention group
Group type: EXPERIMENTAL
Intervention: Values of I below the 10th percentile
Number of subjects: 0
Study 32284450 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent resistance-aerobic training for 16 weeks, 60 min three times a week
Number of subjects: 40
Study 32284450 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 36175740 — intervention group
Group type: EXPERIMENTAL
Intervention: STOPP/START
Number of subjects: 123
Study 36175740 — intervention group
Group type: COMPARATOR
Intervention: PIM-Check
Number of subjects: 123
Study 32959481 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive-behavioural therapy (ICBT) with brief weekly telephone support
Number of subjects: 68
Study 32959481 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 68
Study 32959481 — intervention group
Group type: EXPERIMENTAL
Intervention: ICBT group
Number of subjects: 68
Study 32164773 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive corrective exercises program (CCEP) conducted three times a week for 8 weeks, followed by 4 weeks of detraining
Number of subjects: 22
Study 32164773 — intervention group
Group type: COMPARATOR
Intervention: Control group doing their daily activities
Number of subjects: 22
Study 35287166 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 0
Study 35287166 — intervention group
Group type: COMPARATOR
Intervention: Nicotine patch
Number of subjects: 0
Study 35287166 — intervention group
Group type: COMPARATOR
Intervention: Nicotine patch + mini‐lozenge
Number of subjects: 0
Study 32087841 — intervention group
Group type: EXPERIMENTAL
Intervention: MICUNAY (Motivational Interviewing and Culture for Urban Native American Youth) + CWG (Community Wellness Gathering)
Number of subjects: 185
Study 32087841 — intervention group
Group type: COMPARATOR
Intervention: CWG (Community Wellness Gathering) only
Number of subjects: 185
Study 35924071 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group with injection speeds of 2.3/2.4/2.5/2.6/2.7/2.8/2.9 ml/s and 350 mgI/ml contrast agents, injection time fixed at 10 s.
Number of subjects: 280
Study 35924071 — intervention group
Group type: COMPARATOR
Intervention: Control group with a fixed injection flow rate of 3.5 ml/s, time was 12 s with a total of 42 ml.
Number of subjects: 280
Study 33847663 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 0
Study 33847663 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 0
Study 34776152 — intervention group
Group type: EXPERIMENTAL
Intervention: XBOX (n = 15)
Number of subjects: 29
Study 34776152 — intervention group
Group type: COMPARATOR
Intervention: CONTROL (n = 14)
Number of subjects: 29
Study 34180947 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg)
Number of subjects: 18
Study 34180947 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 34544904 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Stretching (DS)
Number of subjects: 30
Study 34544904 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Stretching followed by Foam Rolling (DS + FR)
Number of subjects: 30
Study 32732154 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (3,666 mg/day for 3 months)
Number of subjects: 100
Study 32732154 — intervention group
Group type: COMPARATOR
Intervention: Corn oil supplement (control)
Number of subjects: 100
Study 32732154 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 100
Study 32200051 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based non-weight bearing (NWB) quadriceps strengthening
Number of subjects: 128
Study 32200051 — intervention group
Group type: COMPARATOR
Intervention: Weight bearing (WB) functional exercise
Number of subjects: 128
Study 35815079 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronally advanced flap with Biomesh® membrane
Number of subjects: 20
Study 35815079 — intervention group
Group type: COMPARATOR
Intervention: Coronally advanced flap only
Number of subjects: 20
Study 34132697 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced feedback
Number of subjects: 2624
Study 34132697 — intervention group
Group type: COMPARATOR
Intervention: Standard PRO monitoring
Number of subjects: 2624
Study 32239498 — intervention group
Group type: EXPERIMENTAL
Intervention: High plant α-diversity
Number of subjects: 0
Study 32239498 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate plant α-diversity in six-plot combinations
Number of subjects: 0
Study 32239498 — intervention group
Group type: EXPERIMENTAL
Intervention: High plant α-diversity in six-plot combinations
Number of subjects: 0
Study 32239498 — intervention group
Group type: EXPERIMENTAL
Intervention: Homogeneous plant α-diversity
Number of subjects: 0
Study 32239498 — intervention group
Group type: EXPERIMENTAL
Intervention: Varying heterogeneity in six-plot combinations
Number of subjects: 0
Study 36151529 — intervention group
Group type: EXPERIMENTAL
Intervention: Training GPs to offer treatment as the default choice using an encounter decision aid (paper or electronic).
Number of subjects: 106
Study 36151529 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care group receives a brief refresher training about smoking cessation without changing their behaviour.
Number of subjects: 106
Study 36151529 — intervention group
Group type: EXPERIMENTAL
Intervention: Consulting a GP who received the intervention.
Number of subjects: 106
Study 32476455 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention to decrease sedentary time (includes paper and digital information, exercise movie, activity planner, pedometer and Fitbit Flex™, personal activity coach, individualized digital training program)
Number of subjects: 94
Study 32476455 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control phase)
Number of subjects: 94
Study 35238084 — intervention group
Group type: EXPERIMENTAL
Intervention: NST plus AMX + MTZ
Number of subjects: 37
Study 35238084 — intervention group
Group type: COMPARATOR
Intervention: NST alone
Number of subjects: 37
Study 34586338 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletonized ITA
Number of subjects: 2161
Study 34586338 — intervention group
Group type: COMPARATOR
Intervention: Pedicled ITA
Number of subjects: 2161
Study 35716471 — intervention group
Group type: EXPERIMENTAL
Intervention: Gyejibongnyeong-Hwan (GBH) treatment for 8 weeks
Number of subjects: 40
Study 35716471 — intervention group
Group type: EXPERIMENTAL
Intervention: Gyejibongnyeong-Hwan (GBH) treatment
Number of subjects: 40
Study 35716471 — intervention group
Group type: COMPARATOR
Intervention: Wait-List group
Number of subjects: 40
Study 33823028 — intervention group
Group type: EXPERIMENTAL
Intervention: Push intervention (16 weeks of lower extremity strengthening, function, and endurance training)
Number of subjects: 89
Study 36349190 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lumbar plexus block (group L)
Number of subjects: 80
Study 36349190 — intervention group
Group type: COMPARATOR
Intervention: Transversus abdominis plane block (group T)
Number of subjects: 80
Study 33188075 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential two-step cell-based assay measuring TNF-α production by CD14+16+ intermediate monocytes after EBV peptide stimulation
Number of subjects: 87
Study 33188075 — intervention group
Group type: EXPERIMENTAL
Intervention: Assay based on examination of early mature B (eBm5) cells
Number of subjects: 87
Study 33188075 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential cell-based assay examining monocyte and eBm5 cell response to EBV peptides
Number of subjects: 87
Study 35031013 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestational diabetes mellitus (GDM) treatment
Number of subjects: 19
Study 35031013 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediabetes at the time of confirmation of pregnancy
Number of subjects: 19
Study 35031013 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and BMI
Number of subjects: 19
Study 35031013 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal height
Number of subjects: 19
Study 34147308 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth-delivered dietary counseling via telephone
Number of subjects: 156
Study 34147308 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth-delivered dietary counseling via telephone (direct contact with patient)
Number of subjects: 156
Study 34147308 — intervention group
Group type: COMPARATOR
Intervention: Telehealth-delivered dietary counseling via telephone (contact through nursing homes)
Number of subjects: 156
Study 32916607 — intervention group
Group type: EXPERIMENTAL
Intervention: Alogliptin
Number of subjects: 5380
Study 32916607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5380
Study 34507360 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile jet lavage
Number of subjects: 20
Study 34507360 — intervention group
Group type: COMPARATOR
Intervention: Syringe lavage
Number of subjects: 20
Study 32974931 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 337
Study 32974931 — intervention group
Group type: COMPARATOR
Intervention: Education
Number of subjects: 337
Study 34596714 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical music ratings
Number of subjects: 20
Study 34596714 — intervention group
Group type: EXPERIMENTAL
Intervention: Jazz music ratings
Number of subjects: 20
Study 34596714 — intervention group
Group type: EXPERIMENTAL
Intervention: Soul music ratings
Number of subjects: 20
Study 34596714 — intervention group
Group type: EXPERIMENTAL
Intervention: STARR test
Number of subjects: 20
Study 34596714 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix test
Number of subjects: 20
Study 34310464 — intervention group
Group type: EXPERIMENTAL
Intervention: rAAV2/2‐ND4 gene therapy
Number of subjects: 76
Study 1986130709 — intervention group
Group type: EXPERIMENTAL
Intervention: High-salt diet
Number of subjects: 0
Study 1986130709 — intervention group
Group type: COMPARATOR
Intervention: Low-salt diet
Number of subjects: 0
Study 1986130709 — intervention group
Group type: COMPARATOR
Intervention: Control periods (usual diet)
Number of subjects: 0
Study 34991693 — intervention group
Group type: EXPERIMENTAL
Intervention: counseling + EC for 12 weeks
Number of subjects: 60
Study 34991693 — intervention group
Group type: COMPARATOR
Intervention: counseling + nicotine replacement therapy (NRT) for 12 weeks
Number of subjects: 60
Study 32265094 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital monitoring of sleep, meals, and physical activity for 12 weeks
Number of subjects: 57
Study 32265094 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital monitoring plus health coaching for 12 weeks
Number of subjects: 57
Study 32265094 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 57
Study 34526482 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectancy manipulation
Number of subjects: 0
Study 32235281 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted radical cystectomy (RARC)
Number of subjects: 0
Study 32235281 — intervention group
Group type: COMPARATOR
Intervention: Open radical cystectomy (ORC)
Number of subjects: 0
Study 36030390 — intervention group
Group type: EXPERIMENTAL
Intervention: Asundexian 10 mg
Number of subjects: 1601
Study 36030390 — intervention group
Group type: EXPERIMENTAL
Intervention: Asundexian 20 mg
Number of subjects: 1601
Study 36030390 — intervention group
Group type: EXPERIMENTAL
Intervention: Asundexian 50 mg
Number of subjects: 1601
Study 36030390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1601
Study 34551263 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion intervention (three-session social cognitive theory-informed)
Number of subjects: 302
Study 34551263 — intervention group
Group type: COMPARATOR
Intervention: Health awareness control (one-session)
Number of subjects: 302
Study 36461619 — intervention group
Group type: EXPERIMENTAL
Intervention: THRIVE (100% oxygen, 40 L/min)
Number of subjects: 40
Study 36461619 — intervention group
Group type: COMPARATOR
Intervention: Facemask (100% oxygen, 6 L/min)
Number of subjects: 40
Study 35104066 — intervention group
Group type: EXPERIMENTAL
Intervention: High volume resistance training (3 sets per exercise)
Number of subjects: 38
Study 35104066 — intervention group
Group type: COMPARATOR
Intervention: Low volume resistance training (1 set per exercise)
Number of subjects: 38
Study 33068792 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen suppression for 6 months, starting either 4 months before or concurrently with definitive prostate radiation therapy
Number of subjects: 426
Study 32534568 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D index
Number of subjects: 371
Study 32534568 — intervention group
Group type: EXPERIMENTAL
Intervention: AQLQ
Number of subjects: 371
Study 32534568 — intervention group
Group type: EXPERIMENTAL
Intervention: VAS
Number of subjects: 371
Study 35123016 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% HP (4 sessions, 1x/week)
Number of subjects: 100
Study 35123016 — intervention group
Group type: EXPERIMENTAL
Intervention: Violet LED (4 sessions, 1x/week)
Number of subjects: 100
Study 35123016 — intervention group
Group type: EXPERIMENTAL
Intervention: Violet LED (4 sessions, 2x/week)
Number of subjects: 100
Study 35123016 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid technique (violet LED + 35% HP; 4 sessions, 1x/week)
Number of subjects: 100
Study 33368190 — intervention group
Group type: EXPERIMENTAL
Intervention: Clever Kids programme (n=20)
Number of subjects: 40
Study 33368190 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition (n=20)
Number of subjects: 40
Study 33922507 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich tuna oil capsules (6 capsules per day) for 8 weeks
Number of subjects: 53
Study 33922507 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Sunola oil) capsules (6 capsules per day) for 8 weeks
Number of subjects: 53
Study 33243198 — intervention group
Group type: EXPERIMENTAL
Intervention: LPG intervention (stove and free fuel)
Number of subjects: 120
Study 33243198 — intervention group
Group type: COMPARATOR
Intervention: Biomass cookfuel
Number of subjects: 120
Study 33243198 — intervention group
Group type: EXPERIMENTAL
Intervention: LPG cookfuel
Number of subjects: 120
Study 33009191 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine and propofol (group DP)
Number of subjects: 39
Study 33009191 — intervention group
Group type: COMPARATOR
Intervention: Propofol alone (group P)
Number of subjects: 39
Study 32037784 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent exercise with post-activation potentiation (CE-PAP)
Number of subjects: 11
Study 32037784 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercise (SE) only
Number of subjects: 11
Study 32037784 — intervention group
Group type: COMPARATOR
Intervention: Concurrent exercise (CE)
Number of subjects: 11